FIELD: medicine, immunology. SUBSTANCE: immunomodulating agent is a matrix no containing the specified antigens or antigenic determinants but containing at least one lipid and one saponine, preferably quil-A. Saponines from beta-Amirine type with carbohydrate fragments 8-11 (molecular mass are 1988, 2150 and 1862 Da) are used as a saponine source. EFFECT: development of new adjuvants. 6 cl, 7 ex, 5 tbl, 14 dwg
Title | Year | Author | Number |
---|---|---|---|
INFLUENZA VACCINE | 2011 |
|
RU2583297C2 |
FUNCTIONALLY RECONSTRUCTED ADJUVANT-CONTAINING VIRUS MEMBRANES | 2004 |
|
RU2348428C2 |
NEW ADJUVANT COMPOSITIONS | 2009 |
|
RU2510280C2 |
NEW VACCINE COMPOSITIONS COMPRISING IMMUNOSTIMULATORY OLIGONUCLEOTIDES | 2014 |
|
RU2627447C2 |
SACCHARIDE CONJUGATED VACCINES | 2005 |
|
RU2454244C2 |
EHRLICHIA VACCINES AND IMMUNOGENIC COMPOSITIONS | 2020 |
|
RU2824881C2 |
USE OF MONOMYCOLYL GLYCEROL (MMG) AS ADJUVANT | 2008 |
|
RU2479317C2 |
METHODS OF PRODUCING ADJUVANTED VIROSOME AND ADJUVANTED VIROSOMES, OBTAINED BY SAID METHODS | 2014 |
|
RU2694367C2 |
CARRIER OF ANTIGENS | 2006 |
|
RU2322259C1 |
METHOD FOR PREPARING CARRIER OF ANTIGENS BASED ON LIPIDS FROM SEA MACROPHYTES AND TRITERPENE GLYCOSIDE CUCUMARIOSIDE | 2005 |
|
RU2319506C2 |
Authors
Dates
1998-10-20—Published
1989-09-28—Filed